Recommendations for diagnosis and treatment of onychomycosis during the COVID-19 pandemic
Dermatol Ther
.
2020 Jul;33(4):e13709.
doi: 10.1111/dth.13709.
Epub 2020 Jun 25.
Authors
Shari R Lipner
1
,
Jose W Ricardo
1
Affiliation
1
Department of Dermatology, Weill Cornell Medicine, New York, New York, USA.
PMID:
32474984
PMCID:
PMC7300483
DOI:
10.1111/dth.13709
No abstract available
Publication types
Letter
Review
MeSH terms
Antifungal Agents / therapeutic use*
Betacoronavirus
COVID-19
Coronavirus Infections / epidemiology*
Humans
Onychomycosis / diagnosis*
Onychomycosis / therapy*
Pandemics
Pneumonia, Viral / epidemiology*
SARS-CoV-2
Substances
Antifungal Agents